Contract research news in brief

December 12, 2012
Research and Development AMRI, Covance, Dimensione Ricerca, INC Research, Perceptive Informatics, TFS

TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates from Covance, Perceptive Informatics and …

EC approves new Xaluprine formulation

December 12, 2012
Research and Development

The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl …

NHS image

First CCGs get green light

December 11, 2012
Sales and Marketing CB, CCGs, Hunt, Lansley, NHS

In a landmark development for the controversial Health and Social Care Act, the first clinical commissioning groups (CCGs) have taken …

USP postpones work on elemental impurities

December 11, 2012
Manufacturing and Production

The US Pharmacopeial Convention (USP) has postponed the publication of new chapters on elemental impurities after an appeal by drugmakers …

Boehringer to make cancer antibody for Apexigen

December 11, 2012
Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer

Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …

EMA building

EMA sets out stall on medicine shortages

December 11, 2012
Manufacturing and Production EMA, GMP, shortages

The European Medicines Agency has called for action at the EU level to tackle the issue of medicine shortages caused …

Pharma manufacturing news in brief

December 11, 2012
Manufacturing and Production AMRI, Hovione, NextPharma Tech, Recipharm, Sanner, Solvias

AMRI renews a key contract with GE, NextPharma sells off US unit Bioserv, plus facility updates for Sanner and Recipharm …

abpi_reception_right

Pharma applauds government strategy

December 11, 2012
Sales and Marketing ABPI, BIA, Cameron, Willetts

The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …

Perjec

Perjeta reduces risk of death

December 11, 2012
Sales and Marketing Cancer, Perjeta, Roche

Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …

screen_shot_2012-12-11_at_09

Life Healthcare adds three heads to its team

December 11, 2012
Medical Communications, Sales and Marketing Life Healthcare

Comms agency Life Healthcare Communications has added Steve Lewis, Helen Gillingham and Rosie Hider to its creative output.

Growth in GP drug prescriptions

December 11, 2012
Sales and Marketing GPs, NHS, UK, doctors, prescribing

The volume of GP-prescribed drugs grew by an annual average of 8.4% in the years 1995-2010, according to new government …

janssen image

Alzheimer’s drug lowers mortality

December 7, 2012
Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly

A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …

abpi_reception

Add value, pharma urged

December 7, 2012
Medical Communications, Sales and Marketing ABPI, CCGs, NHS, Pharmafocus, Prescriber

Pharma will only form lasting relationships with the NHS in future by demonstrating its value, according to Kevin Blakemore, NHS …

Sanofi image

Working Life: Caroline Horwood

December 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Circassia appoints new head to its Board of directors

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …

Protein image

Protein Sciences builds flu vaccine facility

December 6, 2012
Manufacturing and Production FDA, Protein

US drugmaker Protein Sciences has taken over a manufacturing facility formerly owned by Pfizer’s Wyeth unit as it prepares for …

‘Open door’ for pharma

December 6, 2012
Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK

The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

nhs_trees

‘Risk share’ with us, say CCGs

December 6, 2012
Sales and Marketing CCGs, NHS, Pharmafocus, Prescriber, pharma

Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …

hans_008_4189455_rohde_hans

uniQure appoints Basilea’s chief commercial officer

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

screen_shot_2012-12-05_at_10

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …

The Gateway to Local Adoption Series

Latest content